Langley, R., Thaci, D., Blauvelt, A. ., Tsai, T.-F., Miller, M. ., Yu, J., Shen, Y.-K. ., You, Y., Yang, Y.-W., Papp, K. ., Puig, L. and Foley, P. (2022) “Low Risk of Serious Infections and Infections of Interest in Psoriasis Patients Treated with Guselkumab (GUS) for up to 5 Years in VOYAGE (VOY) 1&2 Phase 3 Trials”, SKIN The Journal of Cutaneous Medicine, 6(2), p. s1. doi: 10.25251/skin.6.supp.1.